DossierENTITY

cancer treatment programmes

Coverage of cancer treatment programmes in the Nexus archive.

Earliest in view: May 29 · 05:29 UTCMost recent: May 29 · 05:29 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSMay 29 · 05:29 UTCSCMP CHINA
China’s Innovent Biologics signs US$10.5 billion Pfizer deal for 12 cancer drug trials
Innovent Biologics and Pfizer have signed a $10.5 billion collaboration to develop 12 cancer treatment programs. Innovent will receive an upfront payment of $650 million and up to $9.85 billion in milestone payments tied to development, regulatory, and commercial goals.